Topical Liposomal Amphotericin B Gel Treatment for Cutaneous Leishmaniasis

Condition:   LeishmaniasisInterventions:   Drug: Topical Amphotericin-B 0.4% liposomal gel;   Drug: PlaceboSponsor:   Soroka University Medical CenterNot yet recruiting - verified November 2015

Source: ClinicalTrials.gov - January 13, 2016 Category: Research Source Type: clinical trials